Abstract:BackgroundForkhead box protein f1 (Foxf1) is associated with cell differentiation, and may be a key player in bone homoeostasis. However, the effect of Foxf1 on osteogenesis of bone marrow-derived mesenchymal stem cells (BMSCs) and ovariectomy-induced bone loss, as well as its clinical implications, is unknown.MethodsBy quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR) and western blotting, we assayed Foxf1 expression in bone tissue, BMSCs, and bone marrow-derived macrophages (BMMs), derived from ovariectomised (OVX) mice, and during osteogenic differentiation and osteoclast differentiation. Using a loss-of-function approach (small interfering RNA [siRNA]-mediated knockdown) in vitro, we examined whether Foxf1 regulates osteoblast differentiation of BMSCs via the Wnt/β-catenin signalling pathway. Furthermore, we assessed the anabolic effect of Foxf1 knockdown (siFoxf1) in OVX mice in vivo. We also assayed the expression of Foxf1 in bone tissue derived from postmenopausal osteoporosis (PMOP) patients and its link with bone mineral density (BMD). Finally, we examined the effect of Foxf1 knockdown on the osteoblastic differentiation of human BMSCs.FindingsFoxf1 expression was significantly increased in bone extract and BMSCs from OVX mice and gradually decreased during osteoblastic differentiation of BMSCs but did not differ significantly in OVX mouse-derived BMMs or during osteoclast differentiation. In vitro, Foxf1 knockdown markedly increased the expression of osteoblast specific genes, alkaline phosphatase (ALP) activity, and mineralisation. Moreover, siFoxf1 activated the Wnt/β-catenin signalling pathway. The siFoxf1-induced increase in osteogenic differentiation was partly rescued by inhibitor of Wnt signalling (DKK1). In OVX mice, Foxf1 siRNA significantly reduced bone loss by enhancing bone formation. Foxf1 expression levels negatively correlated with reduced bone mass and bone formation in bone tissue from PMOP patients. Finally, Foxf1 knockdown significantly promoted osteogenesis by human BMSCs.InterpretationOur findings indicate that Foxf1 knockdown promotes BMSC osteogenesis and prevents OVX-induced bone loss. Therefore, Foxf1 has potential as a biomarker of osteogenesis and may be a therapeutic target for PMOP.

Forkhead box O-1 regulates the biological behavior of BMP-2-induced human bone mesenchymal stem cells through mitochondrial dynamics and autophagy

Knockdown of FOXA2 Enhances the Osteogenic Differentiation of Bone Marrow-Derived Mesenchymal Stem Cells Partly Via Activation of the ERK Signalling Pathway

Foxc2 Regulates Osteogenesis and Angiogenesis of Bone Marrow Mesenchymal Stem Cells

Foxf1 knockdown promotes BMSC osteogenesis in part by activating the Wnt/β-catenin signalling pathway and prevents ovariectomy-induced bone loss

Hypoxia-induced Mitochondrial Fission Regulates the Fate of Bone Marrow Mesenchymal Stem Cells by Maintaining HIF1α Stabilization

Low-dose Suspended Graphene Oxide Nanosheets Induce Antioxidant Response and Osteogenic Differentiation of Bone Marrow-Derived Mesenchymal Stem Cells Via JNK-dependent FoxO1 Activation

The Forkhead Transcription Factor Foxc2 Stimulates Osteogenesis in MC3T3-E1 Cells

Activation of autophagy by FOXO3 regulates redox homeostasis during osteogenic differentiation.

Foxc2 Over-Expression in Bone Marrow Mesenchymal Stem Cells Stimulates Osteogenic Differentiation and Inhibits Adipogenic Differentiation

A functional autophagy pathway is essential for BMP9-induced osteogenic differentiation of mesenchymal stem cells (MSCs)

Foxc2 and BMP2 Induce Osteogenic/Odontogenic Differentiation and Mineralization of Human Stem Cells from Apical Papilla.

FOXO1-suppressed miR-424 regulates the proliferation and osteogenic differentiation of MSCs by targeting FGF2 under oxidative stress

The role of FOXO1-mediated autophagy in the regulation of bone formation

Matricellular Protein SMOC2 Potentiates BMP9-Induced Osteogenic Differentiation in Mesenchymal Stem Cells through the Enhancement of FAK/PI3K/AKT Signaling

Overexpression of Bone Morphogenetic Protein-1 Promotes Osteogenesis of Bone Marrow Mesenchymal Stem Cells in Vitro

Melatonin Promotes the BMP9-induced Osteogenic Differentiation of Mesenchymal Stem Cells by Activating the AMPK/β-catenin Signalling Pathway.

FOXO3 Mediates Tooth Movement by Regulating Force-Induced Osteogenesis

BMP9-regulated Angiogenic Signaling Plays an Important Role in the Osteogenic Differentiation of Mesenchymal Progenitor Cells.

FOXO3 is Targeted by Mir-223-3p and Promotes Osteogenic Differentiation of Bone Marrow Mesenchymal Stem Cells by Enhancing Autophagy

Roles of SATB2 in site-specific stemness, autophagy and senescence of bone marrow mesenchymal stem cells

The Osteoconductivity of Biomaterials is Regulated by Bone Morphogenetic Protein 2 Autocrine Loop Involving Α2β1 Integrin and Mitogen-Activated Protein Kinase/Extracellular Related Kinase Signaling Pathways